| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 03/14/2002 | CA2421506A1 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 03/14/2002 | CA2421251A1 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen |
| 03/13/2002 | EP1186295A1 Pharmaceutical preparations containing extracts of soy isoflavone and probiotic micro-organisms |
| 03/13/2002 | EP1185862A2 Method and compositions relating to insulin resistance disorders |
| 03/13/2002 | EP1185673A2 Novel calpains and their use |
| 03/13/2002 | EP1185549A2 Dna encoding a human subunit of the 5-ht3 serotonin receptor |
| 03/13/2002 | EP1185542A2 Purine derivatives |
| 03/13/2002 | EP1185540A1 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents |
| 03/13/2002 | EP1185535A1 Cyclocarbamate and cyclic amide derivatives |
| 03/13/2002 | EP1185530A1 Imidazo- and pyrrolo[1,2-a]pyrimid-4-ones as gonadotropin-releasing hormone receptor antagonists |
| 03/13/2002 | EP1185295A2 Adenosine diphosphatase and activators thereof and their medical uses |
| 03/13/2002 | EP1185294A2 Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders |
| 03/13/2002 | EP1185284A1 47 human secreted proteins |
| 03/13/2002 | EP1185276A1 Isophosphoramide mustard analogs and use thereof |
| 03/13/2002 | EP1185272A2 Novel use of 1-[4-(5-cyanoindol-3yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine and its physiological acceptable salts |
| 03/13/2002 | EP0869957B1 3(2h)-pyridazinone derivatives and pharmaceutical compositions containing these compounds |
| 03/13/2002 | CN1340049A 4-heterocyclylsulfonamide)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl-or-pyridylpyrimidines as endothelin receptor antagonists |
| 03/13/2002 | CN1340045A 5-HTIF agonists |
| 03/13/2002 | CN1339971A Application polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of tumor and diabetes mellitus |
| 03/13/2002 | CN1339299A Method for preparing medicine for urogenital system |
| 03/13/2002 | CN1339298A Compound traditional medicine with piperine for increasing biological utilization of paeoniflorin and its preparing method |
| 03/13/2002 | CN1080718C Vitamin D amine and amine derivatives |
| 03/13/2002 | CN1080565C External-use capsule for curing woman diseases |
| 03/12/2002 | US6355809 Method for preparing (2s)-1-(2r3s)-5-chloro-3-(2-chlorophenyl) -1-(3,4-dimethoxy benzene-sulphonyl) 3-hydroxy-2,3-dihydro-1h-indole-2-carbonyl pyrrolidine-2-carboxamide |
| 03/12/2002 | US6355805 β3-adrenergic receptor agonists |
| 03/12/2002 | US6355670 Skin disorders |
| 03/12/2002 | US6355666 Protected forms of pharmacologically active agents and uses therefor |
| 03/12/2002 | US6355648 Thio-oxindole derivatives |
| 03/12/2002 | US6355640 Pyrazolopyridine adenosine antagonists |
| 03/12/2002 | US6355633 Contraceptives |
| 03/12/2002 | US6355632 Naphthyl compounds, intermediates, compositions, and methods |
| 03/12/2002 | US6355618 Enzyme inhibitors |
| 03/12/2002 | US6355480 Nucleotide sequences which code preferential protein for use in the treatment of fertility and cell proliferation defects |
| 03/12/2002 | US6355275 Delivering an embolic agent formulation to a blood vessel to fill or plug the blood vessel and/or encourage clot formation so that blood flow through the vessel is reduced or ceases |
| 03/12/2002 | US6355245 Glomerulonephritis,antibodies at low dosage |
| 03/11/2002 | CA2356466A1 Pharmaceutical preparations containing soy isoflavone extracts and probiotic micro-organisms |
| 03/07/2002 | WO2002018623A2 Methods and reagents for protease inhibition |
| 03/07/2002 | WO2002018389A2 Thienopyrimidine |
| 03/07/2002 | WO2002018379A2 7-oxo pyridopyrimidines |
| 03/07/2002 | WO2002018348A2 Quinazoline derivatives as alpha-1 adrenergic antagonists |
| 03/07/2002 | WO2002018346A1 Pyrazole derivatives and their use as protein kinase inhibitors |
| 03/07/2002 | WO2002018343A1 Method for synthesizing flosequinan from 4-fluoroanthranilic acid |
| 03/07/2002 | WO2002018333A1 Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors |
| 03/07/2002 | WO2002017967A1 Method of increasing testosterone and related steroid concentrations in women |
| 03/07/2002 | WO2002017963A2 Modulators of intermediate conductance calcium-activated potassium (ikca) channel activity for treating sexual dysfunction |
| 03/07/2002 | WO2002017946A1 Bioactive fraction of eurycoma longifolia |
| 03/07/2002 | WO2002017944A1 Use of a composition comprising an extract of pollen for the treatment of hormonally-related disorders |
| 03/07/2002 | WO2002017943A1 Use of a composition comprising an extract of pollen for the treatment of disease-related weight gain |
| 03/07/2002 | WO2002017942A1 Use of a composition comprising an extract of pollen for the treatment of irritability |
| 03/07/2002 | WO2002017941A1 Use of a composition comprising an extract of pollen for the treatment of edema |
| 03/07/2002 | WO2002017940A1 Use of a composition comprising an extract of pollen for the treatment of dysphoria |
| 03/07/2002 | WO2002017927A1 Method for treating erectile dysfunction and increasing libido in men |
| 03/07/2002 | WO2002017914A2 Fused pyrrolocarbazoles against inflammation |
| 03/07/2002 | WO2002017880A2 Nitric oxide-producing hydrogel materials |
| 03/07/2002 | WO2001093911A3 Macromolecular drug complexes and compositions containing the same |
| 03/07/2002 | WO2001077181A3 Anti-rhesus d monoclonal antibodies |
| 03/07/2002 | WO2001068033A3 Il-8 receptor antagonists |
| 03/07/2002 | WO2001062258A3 Improvement of implantation rate using ff-mas |
| 03/07/2002 | WO2001062236A3 New drug combinations comprising a norepinephrine reuptake inhibitor and an antimuscarinic agent |
| 03/07/2002 | WO2001058956A3 Antibodies that bind human interleukin-18 and methods of making and using |
| 03/07/2002 | WO2001058949A3 Heterologous polypeptide of the tnf family |
| 03/07/2002 | WO2001057022A3 Pyrazole compositions useful as inhibitors of erk |
| 03/07/2002 | WO2001055219A3 scsCNTFR/NNT-1 FUSION PROTEIN |
| 03/07/2002 | WO2001055178A3 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 03/07/2002 | US20020028921 Pluraflavins and derivatives thereof, process for their preparation and use thereof |
| 03/07/2002 | US20020028848 Administering orally 13-hydroxyoctadeca-9Z,11E-dienoic acid (13-HODE); anticoagulants; cardiovascular, respiratory, gastrointestinal, nervous and psyiatric disorders; autoimmune disease; antiinflammatory agents; bactericides; viricides |
| 03/07/2002 | US20020028846 Compositions and methods for amelioration of human female sexual dysfunction |
| 03/07/2002 | US20020028836 Potassium channel openers |
| 03/07/2002 | US20020028826 HMG-CoA reductase inhibitors and method |
| 03/07/2002 | US20020028815 Novel multicyclic compounds and the use thereof |
| 03/07/2002 | US20020028799 Using protease and phospodiesterase inhibitor |
| 03/07/2002 | US20020028788 Administering estradiol in cyclodextrin adjuvant |
| 03/07/2002 | US20020028449 26 Human secreted proteins |
| 03/07/2002 | US20020028227 Use for cosmetic and dermatological indications, reducing and soothing mucosa and skin erythema, inflammation or reaction caused by internal or external factors, wound healing, etc. |
| 03/07/2002 | US20020028207 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 03/07/2002 | DE10041574A1 Chromenonderivate Chromenonderivate |
| 03/07/2002 | CA2746787A1 Method of increasing testosterone and related steroid concentrations in women |
| 03/07/2002 | CA2424146A1 Use of a composition comprising an extract of pollen for the treatment of hormonally-related disorders |
| 03/07/2002 | CA2424026A1 Use of a composition comprising an extract of pollen for the treatment of dysphoria |
| 03/07/2002 | CA2424011A1 Use of a composition comprising an extract of pollen for the treatment of disease-related weight gain |
| 03/07/2002 | CA2420969A1 Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors |
| 03/07/2002 | CA2420906A1 Use of a composition comprising an extract of pollen for the treatment of edema |
| 03/07/2002 | CA2420852A1 Modulators of intermediate conductance calcium-activated potassium (ikca) channel activity for treating sexual dysfunction |
| 03/07/2002 | CA2420832A1 Methods and reagents for protease inhibition |
| 03/07/2002 | CA2420823A1 Use of a composition comprising an extract of pollen for the treatment of irritability |
| 03/07/2002 | CA2420363A1 Pyrazole derivatives and their use as protein kinase inhibitors |
| 03/07/2002 | CA2420122A1 7-oxo pyridopyrimidines |
| 03/07/2002 | CA2386552A1 Method for synthesizing flosequinan from 4-fluoroanthranilic acid |
| 03/06/2002 | EP1184372A1 Phenoxyphenylheterocycle derivatives as selective serotonin reuptake inhibitors (SSRIs) |
| 03/06/2002 | EP1183330A1 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN |
| 03/06/2002 | EP1183252A1 New pharmaceutically active compounds |
| 03/06/2002 | EP1183245A1 Selective npy (y5) antagonists |
| 03/06/2002 | EP1183240A1 Beta2-adrenoceptor agonists |
| 03/06/2002 | EP1183233A2 Bradykinin receptor antagonists |
| 03/06/2002 | EP1183039A1 Pharmaceutical preparations of bioactive substances extracted from natural sources |
| 03/06/2002 | EP1183032A1 Method of enhancing insulin action |
| 03/06/2002 | EP1183020A2 Use of(-)(3-trihalomethylphenoxy) (4-halophenyl)acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidaemia and hyperuricaemia |
| 03/06/2002 | EP0912186B1 Progestogen-anti-progestogen regimens |
| 03/06/2002 | EP0883403A4 Method for treating sexual dysfunctions |
| 03/06/2002 | EP0876372B1 Heteroarylcarboxamide derivatives |